Literature DB >> 69503

Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine.

N El-Sherif, B J Scherlag, R Lazzara, R R Hope.   

Abstract

The effect of lidocaine on re-entrant ventricular arrhythmias (RVA) was studied in dogs 3-7 days following ligation of the anterior descending coronary artery; direct recordings were made of the re-entrant pathway (RP) from the epicardial surface of the infarction zone (IZ). Lidocaine in a therapeutic dose consistently prolonged refractoriness of potentially RP(s) in the IZ and produced a higher degree of conduction block at a constant heart rate. Conduction in the adjacent normal zone was not affected. The impairment of conduction induced by lidocaine in the RP was directly related to its ability to abolish re-entrant ventricular beats and tachycardia. Gradual slowing of conduction in the RP consistently developed before abolition: lengthening of coupling of extrasystolic beats in surface leads and gradual slowing of ventricular tachycardia rate occurred. The termination of re-entry was characteristically associated with complete block in the RP. A "selectivity hypothesis" for the antiarrhythmic action of lidocaine is proposed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69503     DOI: 10.1161/01.cir.56.3.395

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Comparison of the sodium currents in normal Purkinje fibres and Purkinje fibres surviving infarction--a pharmacological study.

Authors:  A Bril; A A Kinnaird; R Y Man
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

2.  Class III Antiarrhythmics: put to the SWORD?

Authors:  S M Cobbe
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

Review 3.  [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].

Authors:  W Schmitz
Journal:  Klin Wochenschr       Date:  1980-09-15

4.  Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles.

Authors:  S Oshita; H Sada; M Kojima; T Ban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

5.  The influence of hyperkalaemia on the cellular electrophysiology of lignocaine in cardiac tissue.

Authors:  B McGovern; M F Murnaghan
Journal:  Ir J Med Sci       Date:  1984-03       Impact factor: 1.568

6.  Voltage- and time-dependent depression of maximum rate of depolarization of guinea-pig ventricular action potentials by two steroidal antiarrhythmic drugs, CCI 22277 and ORG 6001.

Authors:  T J Campbell
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

7.  A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails.

Authors:  Ajit H Janardhan; Wenwen Li; Vadim V Fedorov; Michael Yeung; Michael J Wallendorf; Richard B Schuessler; Igor R Efimov
Journal:  J Am Coll Cardiol       Date:  2012-11-07       Impact factor: 24.094

Review 8.  Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.

Authors:  C Y Chew; J Collett; B N Singh
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

9.  A comparison of the electrophysiological actions of phentolamine with those of some other antiarrhythmic drugs on tissues isolated from the rat heart.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

10.  Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and bepridil.

Authors:  S Nagashima; T Uematsu; S Araki; T Matsuzaki; M Fukuchi; H Hashimoto; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.